Improving equity of access to cancer clinical trials in Scotland
This report summarises the findings and recommendations of an Equity of Access Short Life Working Group. This is provided as a compilation of work package reports.
Appendix 2: Baseline clinical trials staffing data
Ayrshire & Arran, WosCRN
Number of Staff
- Oncologists are visiting clinicians from Beatson
- 2.42wte band 6 nurses
- 0.1wte 8A Pharmacist for CEPA (Regional Chemotherapy Electronic Prescribing and Administration Service) and
- 1.2wte band 5 pharmacists
Funding Source
- 60k from cancer research network- R&D fund the rest
Vacancies/Gaps
- Not able to cover RN annual leave.
- Gaps- band 5 and band 6 nurse gap but no resource
- no resource for data manager
Forth Valley, WosCRN
Number of Staff
- 5 oncology sessions- breast, haematology, Urology, Lung and Colorectal
2 wte research nurses
Funding Source
- some funding from WosCRN, CSO allocation
Vacancies/Gaps
- 1 wte band 7
Greater Glasgow and Clyde, WOsCRN
Number of Staff
- 36 research PAs- oncology consultants
- 2 PA Pathologists
- 3 research fellows
- 0.4 wte Macmillan funded late effect post
- 22.7wte nurses
- 3wte HCSW/sample handlers
- 31.2wte data managers and admin support
- 1.6 wte clinical trial radiographers
- 2.3wte oncology research pharmacists
- 2PAs Beatson Clinical Research Facilities Director
Funding Source
- data manager posts rely on commercial income
- clinical trial radiographers are charity funded -£106884
- R&D fund oncology PAs,50% of research fellows, part of radiographer and radiotherapist posts, band 7 nurse for ATIMPS, oncology research pharmacists and the 2 PAs for Beatson CRF Director
Vacancies
- 1.8wte clinical oncologist vacancies and 1wte medical oncologist vacancy. Plan for further 1.wte medical oncologist post late 2022
- Beatson CRF Quality Manager
Lanarkshire, WosCRN
Number of Staff
- No research-specific funded Oncology sessions - Oncologists are visiting clinicians from NHS GG&C (Beatson). Service scope – including service levels and services provided - fall under a Service Level Agreement.
- Solid tumours:2.50 WTE Band 6 RN,
- Haematological cancer:1.6 WTE Band 6 RN
Funding Source
- 45% of nurse post funding is from WosCRN, rest R&D
Vacancies/Gaps
- No Research Nurse gaps for Cancer Clinical Trials at the present level of recruitment / activity.
- Gap identifed that would require funding- band 5 clinical trials aseptic pharmacy technician 0.5wte £21645 and band 7 clinical trials aseptic pharmacist 0.5 wte £31775
Grampian, NOSCRN
Number of Staff
- 2 NRS fellowships for breast cancer surgeons and 1 NRS fellowship for GP in cancer - as well as 8.9 sessions for oncologists and 3.7 sessions for haematologists
- 11.2wte nurses, 1.2 wte HCSW
- 7.8 wte data managers
Funding Source
- Funding from NOSCRN support 3.63wte nurses.
- Other posts are funded by R&D and endowments.
- PA sessions for clinicians are a mixture of funding sources including grant, commercial, NHS, academic and research
Vacancies/Gaps
- Consultant vacancies in oncology
Highland, NOSCRN
Number of Staff
- No information on number of oncology sessions
- 4.29wte nurses
- 3.8wte data managers
Funding Source
- Funding from NOSCRN supports
- 0.8wte nurse and 2.2wte data managers.
- Other posts are funded by R&D
Vacancies/Gaps
- Consultant vacancies in oncology
Tayside, NOSCRN
Number of Staff
- NRS researcher support for 9 consultants comprising 18 PAs- 2 Oncologists, 2 Radiologists, 3 Surgeons, 1 Pathologist and 1 Haematologist
- 4.4 FTE nurses
- 2.7 FTE data managers
Funding Source
- Consultant PAs funded through R&D, and academic grants
- Research Nurses: 1.6FTE SCRN, 1.8 R&D 1.0 endowments/Trial income/academic grants/commercial trial income
- Data Mangers: 0.99 FTE SCRN 0.9 FTE R&D, 0.81 FTE endowments/Trial income/ grants
Vacancies/Gaps
- 5.0FTE Oncology consultant vacancies
Borders, SECRN
Number of Staff
- Oncologists are visiting clinicians from Lothian-2 clinical oncologist sessions -breast and lung
- 1.2 wte nursing (0.4 wte supports other areas as well)
- 0.4wte data manager and 0.4wte admin (admin supports other areas)
Funding Source
- 20k from SECRN and CSO allocation total cost of nurse posts for 2022/23 is £83209
Vacancies/Gap
- Band 6 1wte research pharmacy post remains unfilled - currently funding band 5 resource to cover
- Lung oncologist is not research active in NHS Borders
- Haematology vacancies- difficulty recruiting to not able to cover RN annual leave
Dumfies & Galloway, SECRN
Number of Staff
- No information on number of oncology sessions
- 0.6wtenurse,
- 1wte data manager
- 1 wte admin support
Funding Source
- Nurse funded by SECRN
Vacancies/Gaps
- No R&D manager
- No current breast oncologist cover
Fife, SECRN
Number of Staff
- No information on number of oncology sessions
- 3.4 wte nurse and support staff
- 0.5wte pharmacist and 0.6wte pharmacy technicians
Funding Source
- 0.8wte haematology and oncology research nurse funding from SECRN, R&D funds remaining 2.6wte
- R&D fund pharmacy posts
Vacancies/Gaps
- pharmacist post vacant for long period- due to be filled in March 2022 0.5 wte but supports all research
Lothian, SECRN
Number of Staff
- 2 NRS fellowships for cancer, plus haematologist and urological surgeon whose research programmes focus on cancer. 8 oncologists with ring-fenced research time (most are ex-NRS fellows)
- 23.2 wte nurses
- 19.0wte data managers
- 1.0wte EDGE manager
- 6.0wte Tissue consenter/processors
- 1.0wte Pharmacy technician
Funding Source
- Funding from SECRN, CRUK, ECMC, commercial and non-commercial income and R&D, drugs saving reinvested by service into trials pharmacy support
Vacancies/Gaps
- 3.0wte nurse vacancies + supporting SACT Standard of care service due to vacancies there
- 2.0wte data manager vacancies, consultant vacancies in Oncology and Haematology
Contact
Email: cancerpolicyteam@gov.scot